New strategy of reprogramming regulatory T cells may improve cancer therapies

Share this post

Therapies that harness the power of the immune system against cancer have made remarkable progress against certain tumors but still remain ineffective in most cancer patients. A new study describes a method of reprogramming regulatory T cells that usually suppress immune responses into inflammatory cells that not only permit but also intensify an antitumor immune response.

This post was syndicated from Top Health News -- ScienceDaily. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply